Literature DB >> 27270966

Periostin Deficiency Causes Severe and Lethal Lung Injury in Mice With Bleomycin Administration.

Hirofumi Kondoh1, Takashi Nishiyama1, Yoshinao Kikuchi2, Masashi Fukayama2, Mitsuru Saito3, Isao Kii1,4, Akira Kudo1.   

Abstract

Pulmonary capillary leakage followed by influx of blood fluid into the air space of lung alveoli is a crucial step in the progression of acute lung injury (ALI). This influx is due to increased permeability of the alveolar-capillary barrier. The extracellular matrix (ECM) between the capillary and the epithelium would be expected to be involved in prevention of the influx; however, the role of the ECM remains to be addressed. Here, we show that the ECM architecture organized by periostin, a matricellular protein, plays a pivotal role in the survival of bleomycin-exposed mice. Periostin was localized in the alveolar walls. Although periostin-null mice displayed no significant difference in lung histology and air-blood permeability, they exhibited early lethality in a model of bleomycin-induced lung injury, compared with their wild-type counterparts. This early lethality may have been due to increased pulmonary leakage of blood fluid into the air space in the bleomycin-exposed periostin-null mice. These results suggest that periostin in the ECM architecture prevents pulmonary leakage of blood fluid, thus increasing the survival rate in mice with ALI. Thus, this study provides an evidence for the protective role of the ECM architecture in the lung alveoli.
© 2016 The Histochemical Society.

Entities:  

Keywords:  acute lung injury; alveolus; bleomycin; collagen; extracellular matrix; fibronectin; matricellular; periostin; pulmonary leakage; stroma

Mesh:

Substances:

Year:  2016        PMID: 27270966      PMCID: PMC4931763          DOI: 10.1369/0022155416652611

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  52 in total

Review 1.  Progress toward improving animal models for idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; William E Lawson
Journal:  Am J Med Sci       Date:  2011-06       Impact factor: 2.378

2.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

Review 3.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

4.  Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart.

Authors:  Paige Snider; Robert B Hinton; Ricardo A Moreno-Rodriguez; Jian Wang; Rhonda Rogers; Andrew Lindsley; Fang Li; David A Ingram; Donald Menick; Loren Field; Anthony B Firulli; Jeffery D Molkentin; Roger Markwald; Simon J Conway
Journal:  Circ Res       Date:  2008-02-22       Impact factor: 17.367

5.  Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.

Authors:  Payal K Naik; Paul D Bozyk; J Kelley Bentley; Antonia P Popova; Carolyn M Birch; Carol A Wilke; Christopher D Fry; Eric S White; Thomas H Sisson; Nabihah Tayob; Barbara Carnemolla; Paola Orecchia; Kevin R Flaherty; Marc B Hershenson; Susan Murray; Fernando J Martinez; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-05       Impact factor: 5.464

6.  Periostin is an extracellular matrix protein required for eruption of incisors in mice.

Authors:  Isao Kii; Norio Amizuka; Li Minqi; Satoshi Kitajima; Yumiko Saga; Akira Kudo
Journal:  Biochem Biophys Res Commun       Date:  2006-02-14       Impact factor: 3.575

7.  Expression, purification and characterization of soluble recombinant periostin protein produced by Escherichia coli.

Authors:  Issei Takayama; Isao Kii; Akira Kudo
Journal:  J Biochem       Date:  2009-07-24       Impact factor: 3.387

8.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

9.  Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.

Authors:  Malgorzata Wygrecka; Bhola K Dahal; Djuro Kosanovic; Frank Petersen; Brigitte Taborski; Susanne von Gerlach; Miroslava Didiasova; Dariusz Zakrzewicz; Klaus T Preissner; Ralph T Schermuly; Philipp Markart
Journal:  Am J Pathol       Date:  2013-04-04       Impact factor: 4.307

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  3 in total

Review 1.  Periostin function in communication with extracellular matrices.

Authors:  Akira Kudo; Isao Kii
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

Review 2.  Introductory review: periostin-gene and protein structure.

Authors:  Akira Kudo
Journal:  Cell Mol Life Sci       Date:  2017-09-07       Impact factor: 9.261

Review 3.  Periostin and its interacting proteins in the construction of extracellular architectures.

Authors:  Isao Kii; Harumi Ito
Journal:  Cell Mol Life Sci       Date:  2017-09-08       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.